Joe Newell, Chief Operations Officer at Atara Biotherapeutics, Inc. (ATRA), sold 7,000 shares at $23.13 ($162K) on 2020-12-16, disclosed to the SEC on 2020-12-18.
Open-market sale of $162k ATRA by Chief Operations Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.08 | 3,500 | $81K | 49.9% |
| 2 | $23.13 | 3,500 | $81K | 50.1% |
| Total | $23.11 avg | 7,000 | $162K | 100% |
| Filing → |
| ATRA | SELL | 2021-09-24 | $179K | — | Filing → |
| ATRA | SELL | 2021-09-17 | $49K | — | Filing → |
| ATRA | SELL | 2021-08-31 | $53K | — | Filing → |